Main Article Content


SARS CoV 2 (severe acute respiratory syndrome novel corona virus-2) to which the world paid the complete attention to face the Global Emergency Alert. COVID 19 was first identified in Wuhan, province in China on December, 2020. The virus was originated from the Bats and transmitted through other intermediary animals. There are around 12.7 lakhs reported cases and more than 69.4 thousands deaths (06/04/2020) which pave the way for having the health crises in the entire world’s population. The governing bodies of the various countries are quarantining their people to avoid the various stages of CoV spreading. Compared to the SARS CoV (severe acute respiratory syndrome coronavirus) and MERS CoV (Middle East respiratory syndrome coronavirus), the fatality rate was lower. But it provides the major impacts on elder population (fatality rate more than 40-50 %). Normal/ low white cell counts with elevated CRP (C-reactive protein ) severs as the laboratory findings for the SARS CoV 2 with the symptoms of cough, sneeze, difficulties in breathing and fever followed by ARDS (Acute respiratory distress syndrome) and multi organ dysfunction. By complete understanding of CoV 2 Pathogenesis, presently many drugs are repositioning to completely eradicate the COVID 19. So many drugs are under clinical trials in which the Hydroxychloroquine produces the greater effects on SARS CoV. Likewise many drugs are subjected to this mega clinical trial by repositioning the drugs.  AYUSH recommends some of the prophylactics and dietary supplements for the COVID 19. This global emergency was not only for the researchers but also all professionals and their impact to the world’s developed and developing countries still unknown.


SARS CoV2 Epidemic 2020 AYUSH Prophylactics COVID 19 Treatments

Article Details

How to Cite
Aravindhanathan Venkatesan, Sudhakar Kothandan, Arun Radhakrishnan, Gowthamarajan Kuppuswamy, Dhanabal Palanisamy, Balasubramanian Somanathan, & Suresh Bhojraj. (2020). Treatments and Prophylactics for a Global Emergency Alert: COVID 19 using Allopathic and Indian Phytomedicine. International Journal of Research in Pharmaceutical Sciences, 11(SPL1), 68-76.

Most read articles by the same author(s)